drugset / Trial / NCT03634189
Cannabidiol in Patients With Heart Failure Failure in AHA/ACC Stages A-C
Phase 1
Unknown
20 enrolled
Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud
NaSingle-groupOpen-labelTreatment
Summary
Cannabidiol in heart failure
Timeline
- Start
- 2021-03-01
- Primary completion
- 2021-09-01
- Completion
- 2021-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 5 mg/kg | Oral |
| Subject | Cannabidiol | Other / unclassified | 25 mg/kg | Oral |